Whilst North America and Europe dominate the 20B Global Tele-Medicine market, the European market is actually bigger than that of the USA. Both regions have CAGR of circa 20%. APAC (China+) obviously growing rapidly too.
CE approval today is validation of year's of hard work by the ResApp team.
In the coming weeks and months there will likely be plenty of more good news flow and sp catalysts to generate the interest and volumes required to crash through the resistance levels.
Pick 'em up under 0.20 whilst you can IMO. RAP will be a beast.
RAP Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
